Table 2 Patient characteristics between the high dose group and low dose group
| Â | DC | CTL | ||||
|---|---|---|---|---|---|---|
| Â | High dose group | Low dose group | p-value | High dose group | Low dose group | p-value |
(n = 35) | (n = 7) | (n = 36) | (n = 6) | |||
Stage |  |  | p = 0.3053 |  |  | p = 0.0976 |
 III | 12 | 2 |  | 14 | 0 |  |
 IV | 17 | 2 |  | 14 | 5 |  |
 Recurrence | 6 | 3 |  | 8 | 1 |  |
Liver metastasis (pretreatment) |  |  | p = 0.5788 |  |  | p = 1.000 |
 Absence | 30 | 5 |  | 30 | 5 |  |
 Presence | 5 | 2 |  | 6 | 1 |  |